• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Kawamoto ST, Raza ZT, Diaz IP, Novaes J, Camacho K, Hargrave AS, Schwarz EB. Information on medication abortion provided by family planning clinics in California. Contraception 2023;128:110279. [PMID: 37683755 PMCID: PMC10997322 DOI: 10.1016/j.contraception.2023.110279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2023] [Revised: 08/25/2023] [Accepted: 09/04/2023] [Indexed: 09/10/2023]
2
Neninger E, Caceres H, Camacho K, Hernandez M, Santiesteban E, Del Castillo C, Menendez Y, Gonzalez B. P2.01-92 Cimavax-EGF in Combination with First-Line Chemotherapy in III Stage NSCLC. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
3
Hernandez M, Neninger E, Santiesteban E, Camacho K, Hernandez N, Amador R, Acosta S, Gonzalez Y, Jimenez Y, Corella M, Ortiz R, Bello L, Calana A, Pichs G, Cala M, Flores Y, Viada C, Robaina M, Crombet T. Efficacy of racotumomab or nimotuzumab vs docetaxel as second-line therapy for advanced non-small cell lung cancer patients. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy288.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
4
Krezmien MP, Travers JC, Camacho K. Suspension rates of students with autism or intellectual disabilities in Maryland from 2004 to 2015. J Intellect Disabil Res 2017;61:1011-1020. [PMID: 28836311 DOI: 10.1111/jir.12406] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2016] [Revised: 06/28/2017] [Accepted: 07/25/2017] [Indexed: 06/07/2023]
5
Hernandez M, Neninger E, Ortiz R, Camacho K, Amador R, Bello L, Flores Y, Acosta S, Pichs G, Cala M, Corella M, Jimenez Y, Diaz Y, Viada C, Robina M, Valdes A, Mendoza I, Guerra P, Macias A, Crombet T. Switch maintenance therapy with racotumomab or nimotuzumab vs docetaxel for NSCLC patients. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw378.47] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA